0001821825-24-000022.txt : 20240402
0001821825-24-000022.hdr.sgml : 20240402
20240402162156
ACCESSION NUMBER: 0001821825-24-000022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240329
FILED AS OF DATE: 20240402
DATE AS OF CHANGE: 20240402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weaver Kirke
CENTRAL INDEX KEY: 0001959622
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40235
FILM NUMBER: 24814570
MAIL ADDRESS:
STREET 1: 30 HUDSON STREET
STREET 2: FLOOR 33
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Organon & Co.
CENTRAL INDEX KEY: 0001821825
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464838035
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 HUDSON STREET
STREET 2: FL 33
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
BUSINESS PHONE: 551-430-6000
MAIL ADDRESS:
STREET 1: 30 HUDSON STREET
STREET 2: FL 33
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
4
1
wk-form4_1712089307.xml
FORM 4
X0508
4
2024-03-29
0
0001821825
Organon & Co.
OGN
0001959622
Weaver Kirke
C/O ORGANON & CO.
30 HUDSON STREET, FLOOR 33
JERSEY CITY
NJ
07302
0
1
0
0
Gen. Counsel & Corp. Secy.
0
Restricted Stock Units
2024-03-29
4
A
0
23271
0
A
2025-03-29
2027-03-29
Common Stock
23271
23271
D
Stock Option (right to buy)
18.80
2024-03-29
4
A
0
95315
0
A
2025-03-29
2027-03-29
Common Stock
95315
95315
D
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Kirke Weaver
2024-04-02